Multitarget Antithrombotic Effects of Scutellarin On Platelet–Coagulation Hemostasis
American Journal Of Biomedical Science & Pharmaceutical Innovation · 27.04.2026 · 06 (04) · 38-48
DOI: 10.37547/ajbspi/volume06issue04-07 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Biomedical Science & Pharmaceutical Innovation, online erschienen am 27.04.2026. Verfasst von Asatillaev Jahongir und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Scutellarin, a flavonoid-rich compound derived from Erigeron breviscapus–related plant material, has been reported to exert cardiovascular and antithrombotic effects, but its integrated influence on platelet–coagulation hemostasis remains incompletely characterized. Methods: we analyzed the in vitro effects of scutellarin on thrombin time (TT), activated recalcification time (ART), activated partial thromboplastin time (APTT), prothrombin time (PT), and ADP-induced platelet aggregation, as well as its effects on intracellular Ca2+ signaling in platelets.
Results
Scutellarin prolonged TT, ART, APTT, and PT in a concentration-dependent manner, indicating a broad anticoagulant profile spanning both intrinsic and extrinsic/common coagulation pathways. TT increased from a baseline range of 18–25 s to as high as 140 s at 50 μM, while PT reached approximately 85 s at the upper tested concentrations. In platelet studies, scutellarin strongly inhibited the second phase of ADP-induced aggregation and attenuated ADP-evoked intracellular Ca2+ rise by approximately 16–19% without behaving as a simple extracellular Ca2+ chelator. Platelet counts were not significantly reduced.
Conclusions
The available experimental data support scutellarin as a multitarget modulator of platelet–coagulation hemostasis with both antiplatelet and anticoagulant properties. The pattern of response is consistent with interference at several levels, including thrombin/fibrin formation, coagulation-complex assembly on phosphatidylserine-rich membranes, and receptor-linked platelet Ca2+ signaling.
Zitieren
APA
Jahongir, A., Nozim, K., Alisher, M., Rаhmаtjоn, M., O'ljaboy, C., & Nargiza, Y. (2026). Multitarget Antithrombotic Effects of Scutellarin On Platelet–Coagulation Hemostasis. American Journal Of Biomedical Science & Pharmaceutical Innovation, 06(04), 38-48. https://doi.org/10.37547/ajbspi/volume06issue04-07
Vancouver
Jahongir A, Nozim K, Alisher M, Rаhmаtjоn M, O'ljaboy C, Nargiza Y. Multitarget Antithrombotic Effects of Scutellarin On Platelet–Coagulation Hemostasis. American Journal Of Biomedical Science & Pharmaceutical Innovation. 2026;06(04):38-48. doi:10.37547/ajbspi/volume06issue04-07
BibTeX
@article{Jahongir2026,
author = {Jahongir, Asatillaev and Nozim, Khoshimov and Alisher, Mukhtorov and Rаhmаtjоn, Mаmаdаminоv and O'ljaboy, Chanqayev and Nargiza, Yuldasheva},
title = {Multitarget Antithrombotic Effects of Scutellarin On Platelet–Coagulation Hemostasis},
journal = {American Journal Of Biomedical Science & Pharmaceutical Innovation},
year = {2026},
volume = {06},
number = {04},
pages = {38--48},
doi = {10.37547/ajbspi/volume06issue04-07}
}
EUVIMED